Commonwealth Equity Services
RLAY icon

Commonwealth Equity Services’s Relay Therapeutics RLAY Stock Holding History

Commonwealth Equity Services’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,448
Closed -$309K – 3647
2021
Q2 		$309K Sell
8,448
-188
-2% -$6.2K ﹤0.01% 2867
2021
Q1 		$298K Buy
8,636
+188
+2% +$8.16K ﹤0.01% 2774
2020
Q4 		$351K Hold
8,448
– – ﹤0.01% 2443
2020
Q3 		$359K Buy
+8,448
New +$322K ﹤0.01% 2221

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Commonwealth Equity Services's RLAY Position: Q3 2021 in Review

Commonwealth Equity Services sold out of Relay Therapeutics (RLAY) in Q3 2021, closing a stake of 8,448 shares — an estimated $309K sold.

Commonwealth Equity Services first reported a position in RLAY in Q3 2020 and held it in 4 quarters. The position peaked at $359K in Q3 2020. 132 funds tracked by Wall St. Rank hold RLAY as of Q3 2021.

  • Commonwealth Equity Services reported no remaining Relay Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Commonwealth Equity Services sold 8,448 Relay Therapeutics shares in Q3 2021, an estimated $309K.
  • Commonwealth Equity Services first reported a position in Relay Therapeutics in Q3 2020 and held it in 4 quarters.
  • Commonwealth Equity Services's Relay Therapeutics position peaked at $359K in Q3 2020.
  • 132 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2021.

Based on Commonwealth Equity Services's 13F filing for Q3 2021, filed 29 Oct 2021.